← All trials
NCT06630624
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 10, 2024
- Primary completion
- Aug 1, 2029
- Completion date
- Aug 1, 2031
- First posted
- Oct 8, 2024
- Last posted
- Oct 8, 2024
- Enrollment
- 140
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Free University of AmsterdamLead sponsor
- Free University of AmsterdamSponsor investigator
- Immunophotonics, Inc.Collaborator
- Free University of AmsterdamOfficial
- Angiodynamics, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.